Future Science Group to Donate to Antibiotics Action for Every New Member of MedChemNet
(PRWEB UK) 2 September 2015 -- Future Science Group (FSG), a medical and scientific publisher, has announced plans to support Antibiotic Action. FSG will donate £1 for every new member to join MedChemNet during the month of September. MedChemNet is an online network providing an environment for sharing ideas and establishing connections in the medicinal chemistry field.
Providing a catalyst to accelerate progress and encourage collaboration in this ever changing field, MedChemNet is delighted to spend the duration of September highlighting and supporting the work of Antibiotic Action, as it continues to seek to inform and educate all about the need for discovery, research and development of new treatments for bacterial infections.
As FSG continues to gather leading experts from different disciplines across medicinal chemistry, it wants to support Antibiotic Action in helping ensure new antibiotics are available to all who need them. “MedChemNet is dedicated to exploring the challenges in human health posed by antibiotic resistance and engaging academia and industry to discuss the medicinal chemistry, which can overcome these challenges. As such, we are wholeheartedly in support of Antibiotics Action in its mission to spread the message about the importance of this cause,” said Gerald Clarke, Community Manager. “Antibiotic resistance is one of the greatest threats of the 21st century and we’re delighted to be able to cooperate with Antibiotics Action in its efforts.”
Professor Laura Piddock, Director of Antibiotic Action responded to MedChemNet’s initiative saying “Antibiotic Action welcomes the support that this MedChemNet initiative offers. The dual crisis of antibiotic resistance and the depleted antibiotic pipeline challenge the basis of modern medicine as we know it. Antibiotics are life-saving, life enhancing agents that underpin a range of therapies from cancer chemotherapy regimens to organ and joint replacement surgeries. Antibiotic Action exists to ensure all – public, governmental agencies, regulatory bodies, scientists, healthcare providers – are aware of the need to discover and develop new antibiotic agents and we support and encourage membership of networking groups such as MedChemNet where expertise can be shared and new innovative collaborations can be fostered and encouraged.”
Membership to MedChemNet is completely free and is a hub for medicinal chemistry professionals to find the latest news and opinion in the field while networking and interacting with their peers. It presents the latest medicinal chemistry research and provides a platform for experts to discuss the trends and topics that interest them.
Join MedChemNet and help us to connect the dots – http://www.future-science-group.com/joinmcn_aa/
–ENDS—
About MedChemNet
Medicinal chemistry has evolved into a highly interdisciplinary field, enhanced by the collaborative efforts of experts from a wide spectrum of specialist areas, from chemoinformaticians to chemical biologists. At MedChemNet, we want to provide a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships. Ultimately, we hope this dynamic network will provide a catalyst to accelerate progress and encourage collaboration in this ever changing field. http://www.medchemnet.com
About Antibiotic Action
Antibiotic Action is an independent UK-led global initiative wholly funded by the British Society for Antimicrobial Chemotherapy (BSAC), which is a UK registered charity. Antibiotic Action seeks to inform and educate all about the need for discovery, research and development of new antibiotics. It contributes to national and international activities and acts as a conduit through which all stakeholders are educated on the importance of new ways to treat bacterial infections. Professor Laura JV Piddock, BSAC Chair in Public Engagement and Professor of Microbiology, University of Birmingham is Director of Antibiotic Action which is now a key player on the global stage, working alongside colleagues in Europe, the United States and further afield. Through a network of Antibiotic Action Champions seeks to raise awareness of the crisis of antibiotic resistance and why it is vital to the health of all nations that antibiotics remain the mainstay of modern medicine and are available to all on an equitable basis.
http://www.antibiotic-action.com| http://www.bsac.org.uk
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.future-science-group.com| http://www.futuremedicine.com | http://www.future-science.com
Leela Ripton, Future Science Group, http://www.future-science-group.com/, +44 2083716090, [email protected]
Share this article